World Alzheimer's Day

On 21 September 1994, at its annual conference in Edinburgh, Alzheimer’s Disease International launched World Alzheimer’s Day to mark the federation’s tenth anniversary and to force a private, often hidden illness into public view. The choice of a single date gave campaigners a fixed point around which to build awareness, and for nearly two decades the 21st carried the load alone. In 2012 the organisation expanded the effort into World Alzheimer’s Month, the whole of September, but the 21st remains the focal day, observed each year to challenge the stigma that still surrounds dementia and to press governments and health systems to take it seriously.

A disease with a birthday of its own

The condition itself has a strikingly precise origin, traceable to a single physician and a single patient. In November 1901, a German psychiatrist named Alois Alzheimer, working at the asylum in Frankfurt, admitted a fifty-one-year-old woman called Auguste Deter. She was suffering from profound memory loss, disorientation, paranoia and an inability to manage the simplest tasks, symptoms that in a person so young baffled the medicine of the day. Alzheimer recorded her decline meticulously, and one exchange became famous: when he asked her to write her name, she said, “Ich habe mich sozusagen verloren”, “I have lost myself, so to speak.” Those words have echoed through the century of research that followed.

Auguste Deter died in April 1906, and Alzheimer, who had by then moved to Munich to work under the great psychiatrist Emil Kraepelin, obtained her brain for study. Using new tissue-staining techniques, he found two abnormalities that would define the disease: dense deposits between the nerve cells, now called amyloid plaques, and twisted tangles of fibres inside them, the neurofibrillary tangles. On 3 November 1906 he presented the case to the 37th Conference of South-West German Psychiatrists in Tübingen. The audience, more interested in the next speaker’s talk on compulsive masturbation, asked not a single question. Recognition came slowly.

From case study to named illness

It was Kraepelin, not Alzheimer, who fixed the name. In the 1910 edition of his authoritative textbook of psychiatry, Kraepelin described the pattern of early-onset dementia with plaques and tangles and labelled it “Alzheimer’s disease”, honouring his junior colleague. Alzheimer himself remained cautious, unsure whether he had found a genuinely distinct disorder or an unusual form of the senile dementia already known in older patients. That question, whether Auguste Deter’s early-onset illness was the same as the far commoner dementia of old age, was only resolved decades later, when researchers confirmed that the same plaques and tangles underlie both.

Alzheimer did not live to see his name become one of the most recognised in medicine. He died in 1915, aged fifty-one, the same age as the patient who made him famous, from complications of a heart condition following a bout of illness. For much of the twentieth century the disease he described was treated as a rare curiosity of the middle-aged, while the widespread memory loss of the elderly was dismissed as an inevitable “senility”. Only in the 1970s did the medical consensus shift decisively, recognising Alzheimer’s as the leading cause of dementia and a specific disease process rather than a natural feature of ageing.

The science has moved on considerably since. Researchers have identified the two proteins at the heart of the disease with growing precision: beta-amyloid, which clumps into the plaques Alzheimer saw between the cells, and tau, which forms the tangles inside them. A landmark discovery came in the 1990s when scientists including John Hardy proposed the “amyloid cascade hypothesis”, the idea that the build-up of amyloid triggers the wider disease process, an argument that has driven drug development for three decades even as it has been fiercely contested. Rare inherited forms of the disease, caused by mutations in genes such as those for the amyloid precursor protein and the presenilins, strike people in their forties and fifties and have given researchers a window onto how the illness begins. The far commoner late-onset form has its own strongest genetic risk factor, a variant of a gene called APOE, though age itself remains the largest risk of all.

The federation behind the day

Alzheimer’s Disease International, the body that created World Alzheimer’s Day, was itself founded in 1984 as an umbrella for national Alzheimer’s associations around the globe. It now links well over a hundred member organisations, and its role is co-ordination and advocacy: pooling knowledge, publishing the influential annual World Alzheimer Report, and lobbying the World Health Organization and individual governments to adopt national dementia plans. The reports have been instrumental in putting hard numbers to a condition long shrouded in silence, estimating that more than fifty-five million people worldwide live with dementia, a figure projected to rise steeply as populations age.

The federation’s founding recognised something practical: families caring for a relative with dementia often felt isolated and ashamed, and the illness was rarely discussed openly. By creating a shared day and later a shared month, campaigners gave those families a moment of visibility and solidarity, and gave researchers and charities a predictable window in which to command public attention.

Why the day matters

Dementia is now among the leading causes of death and disability in the developed world, and its burden falls on patients and on the millions of unpaid family carers who look after them, often for years. World Alzheimer’s Day exists to confront the stigma that keeps people from seeking a diagnosis, to argue for earlier detection and better support, and to fund the research that might one day yield an effective treatment. The disease progresses through recognisable stages, from mild forgetfulness through the loss of language and recognition to complete dependence, and there is as yet no cure, only drugs that modestly slow decline and, more recently, antibody therapies that clear amyloid with contested benefit.

The emotional core of the day is the erosion of self. What Auguste Deter described more than a century ago, the sense of having lost herself, remains the cruellest feature of the illness, as it dismantles memory, personality and the recognition of loved ones. Awareness campaigns increasingly stress that a person with dementia remains a person throughout, deserving dignity and connection rather than being written off.

How it is observed

Across September, and concentrated on the 21st, member associations run memory walks, light landmarks in the movement’s purple, hold information sessions and publish personal testimonies from patients and carers. Purple has become the day’s signature colour, appearing on ribbons, buildings and social-media campaigns. Many events pair awareness with fundraising for research and care services, and some focus on training the public and frontline workers to recognise early signs and to interact patiently with people who are confused or distressed. A growing strand of activity centres on the carers themselves, who bear an enormous unpaid burden and whose own health often suffers, and on so-called dementia-friendly communities, where shops, banks and transport staff are trained to help customers who become confused. The day has also become an occasion for people living with early-stage dementia to speak publicly about their experience, countering the assumption that a diagnosis means an immediate loss of voice.

Fun facts

Alois Alzheimer worked with a colleague, Franz Nissl, whose staining method for nerve cells made the discovery possible, and the two men’s collaboration in Munich produced some of the foundational work of modern neuropathology. Auguste Deter’s original case file and the microscope slides of her brain were rediscovered in the archives of the University of Munich in the 1990s, allowing modern scientists to confirm Alzheimer’s original findings almost a century on. The purple colour of the awareness movement was chosen because it combines the calm stability of blue with the energy of red, symbolising the mix of gravity and hope the cause tries to convey. And the disease’s most famous hallmark, amyloid plaque, is now also studied in connection with sleep, since deep rest of the kind promoted on World Sleep Day helps the brain clear the very protein that accumulates in Alzheimer’s.

A Closing Reflection

There is a strange symmetry in a disease of forgetting having so exact a history: a named patient, a dated lecture, a colleague who fixed the name, all preserved when so much else about the illness dissolves. World Alzheimer’s Day works against forgetting in two senses at once, resisting the personal erasure the disease inflicts and the social forgetting that lets sufferers slip out of public concern. As with other health observances such as World Hearing Day, the occasion asks people to attend to a faculty most take for granted until it fails. Memory is the thread that binds a life into a single story, and a day that insists we not lose sight of those losing theirs is, in the end, an act of remembering on their behalf.